Author:
Lee Young-Hee,Kim Mi-Jeong,Choi Chang-Ik,Bae Jung-Woo,Jang Choon-Gon,Lee Seok-Yong
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference18 articles.
1. Ahn, S. C., Neuromuscular complications of statins. Phys. Med. Rehabil. Clin. N. Am., 19, 47–59 (2008).
2. Antons, K. A., Williams, C. D., Baker, S. K., and Phillips, P. S., Clinical perspectives of statin-induced rhabdomyolysis. Am. J. Med., 119, 400–409 (2006).
3. Bae, J. W., Kim, H. S., Lee, S. C., Han, K. H., and Jeon, E. S., The safety and efficacy of ezetimibe and simvastatin combination therapy in Korean patients with primary hypercholesterolemia. Kor. J. Int. Med., 68, 487–497 (2005).
4. Bays, H. E., Moore, P. B., Drehobl, M. A., Rosenblatt, S., Toth, P. D., Dujovne, C. A., Knopp, R. H., Lipka, L. J., Lebeaut, A. P., Yang, B., Mellars, L. E., Cuffie-Jackson, C., and Veltri, E. P., Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin. Ther., 23, 1209–1230 (2001).
5. Bhardwaj, S. S. and Chalasani, N., Lipid-lowering agents that cause drug-induced hepatotoxicity. Clin. Liver Dis., 11, 597–613 (2007).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献